Setting up of a hospital Covid-19 vaccination center: A descriptive study.

Scarlett Wise, Fanny Lanternier, Camille Cotteret, C��line Chasport, Virginie Juin-Leonard, Am��lie Cantat, Anne Scemla, Claire Delage, Barbara Mantz, Caroline Telion, Pierre Carli, Pierre Frange, Salvatore Cisternino
Author Information
  1. Scarlett Wise: Pharmacy, H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France. ORCID
  2. Fanny Lanternier: Department of Infectious Diseases and Tropical Medicine H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  3. Camille Cotteret: Pharmacy, H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  4. C��line Chasport: Pharmacy, H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  5. Virginie Juin-Leonard: Administrative Management, H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  6. Am��lie Cantat: Administrative Management, H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  7. Anne Scemla: Department of Nephrology and Adult Kidney Transplantation H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  8. Claire Delage: Department of Nephrology and Adult Kidney Transplantation H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  9. Barbara Mantz: Service d'Aide M��dicale Urgente Paris France.
  10. Caroline Telion: Service d'Aide M��dicale Urgente Paris France.
  11. Pierre Carli: Service d'Aide M��dicale Urgente Paris France.
  12. Pierre Frange: Infection Control Unit, Laboratory of Clinical Microbiology H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.
  13. Salvatore Cisternino: Pharmacy, H��pital Universitaire Necker-Enfants Malades, Assistance Publique des H��pitaux de Paris, AP-HP Paris France.

Abstract

Background and Aims: The coronavirus pandemic challenged countries worldwide in a race against contaminations and variants. Vaccination campaigns were the answer to such an infectious spread. This descriptive study presents the organizational process of the setting up of a Covid-19 vaccination center in a French University Hospital in January 2021, the issues encountered along the way and assessment of adaptability.
Methods: Three major stakeholders: SARS CoV-2 crisis referent, referring vaccination medical doctor and referring vaccination pharmacist retraced key moments and identified issues encountered during the setting up of the vaccination center and its long term maintenance, threw a series of meetings. Records of crisis and periodic meetings that took place threw out the vaccination campaign were consulted.
Results: A multidisciplinary crisis steering committee with nine different professionals was created January 3. Logistics for the vaccination center opening were discussed: location, informatics, appointment-scheduling, pharmaceutical circuit, internal circuit, human resources, and information communication. The vaccination center was ready to welcome healthcare workers in less than 24���h on January 4. The first month, 2757 1st shots were administered, leading up to a total of 9167 1st shots during 6 months of activity. From January to June 2021, the multidisciplinary group dealt and adapted its processes to challenging and unexpected situations. Indeed, issues encountered with Pfizer BioNTech's and AstraZeneca's vaccine, were: supply shortages, vaccine manipulation, targeted populations, pharmacovigilance, and general communication.
Conclusion: This descriptive study provides an exclusive insight on how a hospital vaccination center was organized and adapted during Covid-19 pandemic to ensure healthcare workers' security and resilience, and to protect high risk patients of severe Covid-19 infection.

Keywords

References

  1. Lancet. 2020 Jun 6;395(10239):1760-1761 [PMID: 32464114]
  2. BMJ. 2021 Feb 22;372:n523 [PMID: 33619037]
  3. J Exp Med. 2021 Jul 5;218(7): [PMID: 33890986]
  4. Health Sci Rep. 2022 Nov 30;6(1):e968 [PMID: 36467756]

Word Cloud

Created with Highcharts 10.0.0vaccinationcenterCovid-19Januarypandemicdescriptivestudyissuesencounteredcrisismultidisciplinaryhospitalsetting2021referringthrewmeetingscampaigncircuitcommunicationhealthcare1stshotsadaptedvaccineBackgroundAims:coronaviruschallengedcountriesworldwideracecontaminationsvariantsVaccinationcampaignsanswerinfectiousspreadpresentsorganizationalprocessFrenchUniversityHospitalalongwayassessmentadaptabilityMethods:Threemajorstakeholders:SARSCoV-2referentmedicaldoctorpharmacistretracedkeymomentsidentifiedlongtermmaintenanceseriesRecordsperiodictookplaceconsultedResults:steeringcommitteeninedifferentprofessionalscreated3Logisticsopeningdiscussed:locationinformaticsappointment-schedulingpharmaceuticalinternalhumanresourcesinformationreadywelcomeworkersless24���h4firstmonth2757administeredleadingtotal91676monthsactivityJunegroupdealtprocesseschallengingunexpectedsituationsIndeedPfizerBioNTech'sAstraZeneca'swere:supplyshortagesmanipulationtargetedpopulationspharmacovigilancegeneralConclusion:providesexclusiveinsightorganizedensureworkers'securityresilienceprotecthighriskpatientssevereinfectionSettingcenter:Covid���19managementcooperationorganizationpublichealth

Similar Articles

Cited By